GCase activator reduces α-synuclein in mouse, patient-derived models of PD

DISEASE CATEGORY: Neurology

INDICATION: Parkinson's disease (PD)

Northwestern University researchers, including Lysosomal Therapeutics

Read the full 129 word article

User Sign In